Sharp Therapeutics Corp.
SHRX.V
TSX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -72.55% | -- | 1,246.47% | 435.02% | 824.57% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 70.85% | -- | 112.84% | -- | -29.71% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -71.15% | -- | 964.69% | -- | 726.83% |
|
|
|||||
| Total Current Assets | -71.15% | -- | 964.69% | -- | 726.83% |
| Net Property, Plant & Equipment | -9.65% | -- | -9.32% | -- | -7.77% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 0.00% | -- | 0.00% | -- | 0.00% |
| Total Assets | -57.14% | -- | 203.93% | -- | 194.47% |
|
|
|||||
| Total Accounts Payable | 8.39% | -- | -19.52% | -- | 47.18% |
| Total Accrued Expenses | 119.46% | -- | -72.53% | -- | 10.66% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 200.00% | -- | 55.16% | -- | -99.50% |
| Total Finance Division Other Current Liabilities | -- | -- | -100.00% | -- | -- |
| Total Other Current Liabilities | -- | -- | -100.00% | -- | -- |
| Total Current Liabilities | 38.39% | -- | -96.49% | -- | -91.06% |
|
|
|||||
| Total Current Liabilities | 38.39% | -- | -96.49% | -- | -91.06% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -8.25% | -- | -3.70% | -- | -2.74% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 8.08% | -- | -88.91% | -- | -84.89% |
|
|
|||||
| Common Stock & APIC | 15.39% | -- | 385.94% | -- | 336.87% |
| Retained Earnings | -31.05% | -- | -14.86% | -- | -19.61% |
| Treasury Stock & Other | -721.31% | -- | -- | -- | -- |
| Total Common Equity | -106.83% | -- | 116.93% | 94.23% | 122.51% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -106.83% | -- | 116.93% | 94.23% | 122.51% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -106.83% | -- | 116.93% | 94.23% | 122.51% |
|
|
|||||